Search Thermo Fisher Scientific
Search Thermo Fisher Scientific
Biomanufacturing has evolved from classical protein biologicals and vaccines to a diverse number of current products and therapeutics—such as mRNA vaccines, medical devices, and tissue, cell, and gene therapies. Approaches to buffer preparation has become more important of late due to this increase in product offerings, increases in volumetric productivity upstream, and developments in bioprocessing materials, processes, and facilities. Labor-intensive and inflexible buffer supply methods can impose financial and operational stress, as well as processing bottlenecks. We can help you streamline processes so you can focus on developing therapies to help meet growing population needs.
Take a video tour of our newly expanded facility in Paisley, Scotland—similar in scale and offering the same level of quality solutions as our Grand Island, New York facility.
The expansion helps meet the increasing global demand for more complex molecule development and increases the site’s capacity to produce critical raw materials used in the development and manufacturing of biologic therapies.
Our Process Walk program is designed to drive process optimization and reduce cost. View examples across the bioprocessing workflow where technical engagement helped to drive performance through collaboration.
Access a targeted collection of scientific application notes, case studies, posters, white papers and more for bioprocessing:
For research use or further manufacturing. Not for diagnostic use or direct administration into humans or animals.